A detailed history of Integrated Investment Consultants, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Integrated Investment Consultants, LLC holds 338,118 shares of BMY stock, worth $19.6 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
338,118
Holding current value
$19.6 Million
% of portfolio
0.38%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$39.66 - $51.75 $13.4 Million - $17.5 Million
338,118 New
338,118 $17.5 Million
Q4 2023

Jan 23, 2024

SELL
$48.48 - $57.85 $11,247 - $13,421
-232 Reduced 5.43%
4,037 $207,000
Q3 2023

May 28, 2024

BUY
$57.89 - $64.73 $219,866 - $245,844
3,798 New
3,798 $220,000
Q3 2023

Oct 17, 2023

SELL
$57.89 - $64.73 $35,139 - $39,291
-607 Reduced 12.45%
4,269 $247,000
Q2 2023

Jul 18, 2023

BUY
$63.71 - $70.74 $43,577 - $48,386
684 Added 16.32%
4,876 $311,000
Q1 2023

Jul 18, 2023

BUY
$65.71 - $74.53 $39,688 - $45,016
604 Added 12.39%
5,480 $379,000
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $16,777 - $19,867
245 Added 6.21%
4,192 $301,000
Q3 2022

Nov 21, 2022

SELL
$0.13 - $76.84 $41 - $24,819
-323 Reduced 7.56%
3,947 $281,000
Q2 2022

Jul 19, 2022

SELL
$72.62 - $79.98 $15,613 - $17,195
-215 Reduced 4.79%
4,270 $329,000
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $22,378 - $26,834
364 Added 8.83%
4,485 $328,000
Q4 2021

Jan 10, 2022

SELL
$53.63 - $62.52 $15,391 - $17,943
-287 Reduced 6.51%
4,121 $257,000
Q3 2021

Oct 28, 2021

BUY
$59.17 - $69.31 $5,443 - $6,376
92 Added 2.13%
4,408 $261,000
Q2 2021

Jul 21, 2021

BUY
$61.91 - $67.42 $31,945 - $34,788
516 Added 13.58%
4,316 $288,000
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $20,175 - $22,691
340 Added 9.83%
3,800 $240,000
Q4 2020

Feb 09, 2021

BUY
$57.74 - $65.43 $199,780 - $226,387
3,460 New
3,460 $215,000
Q3 2020

Oct 26, 2020

SELL
$57.43 - $63.64 $207,609 - $230,058
-3,615 Closed
0 $0
Q1 2020

May 22, 2020

SELL
$46.4 - $67.43 $83,937 - $121,980
-1,809 Reduced 33.35%
3,615 $202,000
Q4 2019

Jan 29, 2020

SELL
$49.21 - $64.19 $3,690 - $4,814
-75 Reduced 1.36%
5,424 $348,000
Q3 2019

Oct 21, 2019

SELL
$42.77 - $50.71 $2.48 Million - $2.94 Million
-57,969 Reduced 91.34%
5,499 $279,000
Q2 2018

Aug 01, 2018

BUY
$50.53 - $62.98 $3.03 Million - $3.78 Million
60,035 Added 1748.76%
63,468 $247,000
Q1 2018

Apr 12, 2018

BUY
$59.92 - $68.98 $18,155 - $20,900
303 Added 9.68%
3,433 $217,000
Q3 2017

Oct 26, 2017

BUY
$55.23 - $63.74 $172,869 - $199,506
3,130
3,130 $200,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Integrated Investment Consultants, LLC Portfolio

Follow Integrated Investment Consultants, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Investment Consultants, LLC with notifications on news.